Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.06
+0.09 (1.36%)
At close: May 9, 2025, 4:00 PM
7.38
+0.33 (4.61%)
After-hours: May 9, 2025, 7:49 PM EDT

Seres Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
621421816987652,236
Upgrade
Market Cap Growth
4.42%-21.59%-74.06%-8.81%-65.78%825.56%
Upgrade
Enterprise Value
921692235414611,979
Upgrade
Last Close Price
7.0516.6228.00112.00166.60490.00
Upgrade
PE Ratio
0.841043.26----
Upgrade
PS Ratio
----5.2867.31
Upgrade
PB Ratio
1.2210.29-4.0364.715.8212.79
Upgrade
P/TBV Ratio
1.2210.29-64.715.8212.79
Upgrade
P/OCF Ratio
----114.40-
Upgrade
EV/Sales Ratio
----3.1859.60
Upgrade
Debt / Equity Ratio
1.776.65-4.4315.080.370.23
Upgrade
Asset Turnover
----0.420.14
Upgrade
Quick Ratio
1.970.801.302.123.535.67
Upgrade
Current Ratio
2.110.941.782.283.695.79
Upgrade
Return on Equity (ROE)
----258.04%-42.83%-141.00%
Upgrade
Return on Assets (ROA)
-28.22%-30.43%-34.48%-31.96%-11.55%-23.17%
Upgrade
Return on Capital (ROIC)
-48.44%-58.47%-74.51%-63.51%-20.34%-51.97%
Upgrade
Earnings Yield
118.61%0.10%-62.84%-35.85%-8.57%-3.99%
Upgrade
FCF Yield
--105.01%-69.26%-34.20%-0.38%-4.21%
Upgrade
Buyback Yield / Dilution
-32735.87%-21.40%-18.44%-17.86%-14.93%-40.85%
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q